Market Overview:
The global polyglycol laxatives market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of constipation, rising awareness about the benefits of polyglycol laxatives, and growing demand for over-the-counter (OTC) drugs. Polyglycol 3350 is expected to be the fastest-growing type segment during the forecast period, owing to its high efficacy and safety profile. By application, adult is expected to be the largest segment in terms of revenue during the forecast period.
Product Definition:
Polyglycol laxatives are a type of stool softener. They work by increasing the amount of water in the intestine, which makes it easier for stool to move through the intestines. This can help relieve constipation.
Polyglycol 3350:
Polyglycol 3350 is a synthetic glycolic acid based compound, which has been used as a laxative since the early 70s. It was developed by accident when the attempt to produce polyether ether ketone (PEEK) resulted in the product named Polyglycolic Acid (PGA). PGA has been found to be an effective and safe local anesthetic for use in human medicine.
Polyglycol 4000:
Polyglycol 4000 is a synthetic, semi-synthetic and natural polyether compound. It has the chemical formula as (C4H10O2)n where n is an integer ranging from 200 to 1000. Polyglycol 4000 or PGL is manufactured by reacting ethylene oxide with glycerol in presence of acid catalyst at high pressure and temperature for a longer period of time.
Application Insights:
The adult application segment held the largest market share of more than 60% in 2017. The use of glycol laxatives among adults is more common compared to children as they are able to tolerate the side effects better. Polyglycol products are considered safe for consumption during pregnancy and lactation as there is no evidence suggesting that it can cause harm to babies and mothers, respectively. However, people who suffer from chronic constipation or irritable bowel syndrome (IBS) should avoid using polyglycol products due to possible side effects.
Polyglycol 3350 is one of the most commonly used types in adult applications owing to its high effectiveness against constipation along with lesser number of adverse effects when compared with other types such as Polyglycol 4000 or Polyethylene Terephthalate (PET). Moreover, increasing awareness about health benefits associated with regular exercise and a healthy lifestyle will boost product demand over the forecast period.
Regional Analysis:
North America dominated the global polyglycol laxatives market in 2017. The region is expected to maintain its position during the forecast period owing to increasing cases of constipation, rising geriatric population, and high adoption of natural products. In addition, presence of key players such as Procter & Gamble Company; Cargill Inc.; and Johnson & Johnson Ltd.; will help increase product penetration in North America over the forecast period.
Asia Pacific is anticipated to witness significant growth over the next eight years due to growing geriatric population and increasing awareness about healthy living lifestyles in developing economies including China and India. Moreover, improving economic conditions are also likely to contribute toward increased demand for adult dose polyglycol laxatives which will further boost regional market growth during the same period.
Growth Factors:
- Increasing prevalence of constipation and other gastrointestinal disorders.
- Growing awareness about the benefits of polyglycol laxatives over traditional laxatives.
- Rising demand for over-the-counter (OTC) drugs for the treatment of constipation and other gastrointestinal disorders.
- Technological advancements in the manufacturing of polyglycol laxatives that improve their efficacy and safety profile.
Scope Of The Report
Report Attributes
Report Details
Report Title
Polyglycol Laxatives Market Research Report
By Type
Polyglycol 3350, Polyglycol 4000
By Application
Adult, Child
By Companies
Bayer AG, Boehringer Ingelheim, GSK, Purdue Pharma, Sucampo Pharmaceuticals, Norgine, Cipla, GoodSense, Beaufour Ipsen Industrie
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Polyglycol Laxatives Market Report Segments:
The global Polyglycol Laxatives market is segmented on the basis of:
Types
Polyglycol 3350, Polyglycol 4000
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Adult, Child
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer AG
- Boehringer Ingelheim
- GSK
- Purdue Pharma
- Sucampo Pharmaceuticals
- Norgine
- Cipla
- GoodSense
- Beaufour Ipsen Industrie
Highlights of The Polyglycol Laxatives Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Polyglycol 3350
- Polyglycol 4000
- By Application:
- Adult
- Child
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Polyglycol Laxatives Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Polyglycol laxatives are a type of medication that help to relieve constipation. They work by loosening the contents of the bowel, which makes it easier for the body to pass waste.
Some of the key players operating in the polyglycol laxatives market are Bayer AG, Boehringer Ingelheim, GSK, Purdue Pharma, Sucampo Pharmaceuticals, Norgine, Cipla, GoodSense, Beaufour Ipsen Industrie.
The polyglycol laxatives market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Polyglycol Laxatives Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Polyglycol Laxatives Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Polyglycol Laxatives Market - Supply Chain
4.5. Global Polyglycol Laxatives Market Forecast
4.5.1. Polyglycol Laxatives Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Polyglycol Laxatives Market Size (000 Units) and Y-o-Y Growth
4.5.3. Polyglycol Laxatives Market Absolute $ Opportunity
5. Global Polyglycol Laxatives Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Polyglycol Laxatives Market Size and Volume Forecast by Type
5.3.1. Polyglycol 3350
5.3.2. Polyglycol 4000
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Polyglycol Laxatives Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Polyglycol Laxatives Market Size and Volume Forecast by Application
6.3.1. Adult
6.3.2. Child
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Polyglycol Laxatives Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Polyglycol Laxatives Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Polyglycol Laxatives Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Polyglycol Laxatives Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Polyglycol Laxatives Demand Share Forecast, 2019-2026
9. North America Polyglycol Laxatives Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Polyglycol Laxatives Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Polyglycol Laxatives Market Size and Volume Forecast by Application
9.4.1. Adult
9.4.2. Child
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Polyglycol Laxatives Market Size and Volume Forecast by Type
9.7.1. Polyglycol 3350
9.7.2. Polyglycol 4000
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Polyglycol Laxatives Demand Share Forecast, 2019-2026
10. Latin America Polyglycol Laxatives Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Polyglycol Laxatives Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Polyglycol Laxatives Market Size and Volume Forecast by Application
10.4.1. Adult
10.4.2. Child
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Polyglycol Laxatives Market Size and Volume Forecast by Type
10.7.1. Polyglycol 3350
10.7.2. Polyglycol 4000
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Polyglycol Laxatives Demand Share Forecast, 2019-2026
11. Europe Polyglycol Laxatives Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Polyglycol Laxatives Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Polyglycol Laxatives Market Size and Volume Forecast by Application
11.4.1. Adult
11.4.2. Child
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Polyglycol Laxatives Market Size and Volume Forecast by Type
11.7.1. Polyglycol 3350
11.7.2. Polyglycol 4000
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Polyglycol Laxatives Demand Share, 2019-2026
12. Asia Pacific Polyglycol Laxatives Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Polyglycol Laxatives Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Polyglycol Laxatives Market Size and Volume Forecast by Application
12.4.1. Adult
12.4.2. Child
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Polyglycol Laxatives Market Size and Volume Forecast by Type
12.7.1. Polyglycol 3350
12.7.2. Polyglycol 4000
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Polyglycol Laxatives Demand Share, 2019-2026
13. Middle East & Africa Polyglycol Laxatives Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Polyglycol Laxatives Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Polyglycol Laxatives Market Size and Volume Forecast by Application
13.4.1. Adult
13.4.2. Child
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Polyglycol Laxatives Market Size and Volume Forecast by Type
13.7.1. Polyglycol 3350
13.7.2. Polyglycol 4000
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Polyglycol Laxatives Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Polyglycol Laxatives Market: Market Share Analysis
14.2. Polyglycol Laxatives Distributors and Customers
14.3. Polyglycol Laxatives Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Bayer AG
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Boehringer Ingelheim
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. GSK
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Purdue Pharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Sucampo Pharmaceuticals
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Norgine
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Cipla
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. GoodSense
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Beaufour Ipsen Industrie
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
